• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青藤碱通过下调己糖激酶II介导的有氧糖酵解抑制非小细胞肺癌。

Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis.

作者信息

Liu Wenbin, Yu Xinfang, Zhou Li, Li Jigang, Li Ming, Li Wei, Gao Feng

机构信息

Department of Pathology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410006, People's Republic of China.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

Onco Targets Ther. 2020 Apr 16;13:3209-3221. doi: 10.2147/OTT.S243212. eCollection 2020.

DOI:10.2147/OTT.S243212
PMID:32368080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7176511/
Abstract

BACKGROUND

Addiction to aerobic glycolysis is a common metabolic phenotype in human non-small cell lung cancer (NSCLC). The natural product Sinomenine (Sin) exhibits significant anti-tumor effects in various human cancers. However, the underlying mechanism remains elusive.

METHODS

The inhibitory effect of Sin on NSCLC cells was determined by MTS and soft agar assays. The glycolysis efficacy of NSCLC cells was examined by glucose uptake and lactate production. The activation of Akt signaling and the protein level of hexokinases II (HK2) were examined by immunoblot (IB), qRT-PCR, and immunohistochemical staining (IHC). The in vivo anti-tumor effect of Sin was validated by the xenograft mouse model.

RESULTS

We showed that HK2 is highly expressed in NSCLC tissues and cell lines. Depletion of HK2 suppressed cell viability, anchorage-independent colony formation, and xenograft tumor growth. Sinomenine exhibited a profound inhibitory effect on NSCLC cells by reducing HK2-mediated glycolysis both in vitro and in vivo. Ectopic overexpression of HK2 compromised these anti-tumor efficacies in sinomenine-treated NSCLC cells. Moreover, we revealed that sinomenine decreased Akt activity, which caused the down-regulation of HK2-mediated glycolysis. Knockdown of Akt reduced HK2 protein level and impaired glycolysis. In contrast, overexpression of constitutively activated Akt1 reversed this phenotype.

CONCLUSION

This study suggests that targeting HK2-mediated aerobic glycolysis is required for sinomenine-mediated anti-tumor activity.

摘要

背景

有氧糖酵解成瘾是人类非小细胞肺癌(NSCLC)中常见的代谢表型。天然产物青藤碱(Sin)在多种人类癌症中表现出显著的抗肿瘤作用。然而,其潜在机制仍不清楚。

方法

通过MTS和软琼脂试验确定青藤碱对NSCLC细胞的抑制作用。通过葡萄糖摄取和乳酸生成检测NSCLC细胞的糖酵解效率。通过免疫印迹(IB)、qRT-PCR和免疫组织化学染色(IHC)检测Akt信号通路的激活和己糖激酶II(HK2)的蛋白水平。通过异种移植小鼠模型验证青藤碱的体内抗肿瘤作用。

结果

我们发现HK2在NSCLC组织和细胞系中高表达。HK2的缺失抑制了细胞活力、非锚定依赖性集落形成和异种移植肿瘤生长。青藤碱在体外和体内均通过减少HK2介导的糖酵解对NSCLC细胞表现出显著的抑制作用。HK2的异位过表达削弱了青藤碱处理的NSCLC细胞中的这些抗肿瘤功效。此外,我们发现青藤碱降低了Akt活性,这导致HK2介导的糖酵解下调。敲低Akt降低了HK2蛋白水平并损害了糖酵解。相反,组成型激活的Akt1的过表达逆转了这种表型。

结论

本研究表明,靶向HK2介导的有氧糖酵解是青藤碱介导的抗肿瘤活性所必需的。

相似文献

1
Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis.青藤碱通过下调己糖激酶II介导的有氧糖酵解抑制非小细胞肺癌。
Onco Targets Ther. 2020 Apr 16;13:3209-3221. doi: 10.2147/OTT.S243212. eCollection 2020.
2
Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway.白藜芦醇通过靶向Akt信号通路抑制非小细胞肺癌中己糖激酶II介导的糖酵解。
Exp Cell Res. 2016 Dec 10;349(2):320-327. doi: 10.1016/j.yexcr.2016.11.002. Epub 2016 Nov 6.
3
Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.鱼藤素通过下调己糖激酶II介导的糖酵解来抑制非小细胞肺癌。
Oncotarget. 2017 May 16;8(20):32586-32599. doi: 10.18632/oncotarget.15937.
4
Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.抑制己糖激酶 II 介导的糖酵解有助于胡椒碱诱导非小细胞肺癌细胞中的肿瘤抑制。
Int J Biol Sci. 2019 Mar 1;15(4):826-837. doi: 10.7150/ijbs.31749. eCollection 2019.
5
miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.miR-206 通过靶向己糖激酶 2 调节非小细胞肺癌细胞有氧糖酵解。
J Biochem. 2020 Apr 1;167(4):365-370. doi: 10.1093/jb/mvz099.
6
Hexokinases II-mediated glycolysis governs susceptibility to crizotinib in ALK-positive non-small cell lung cancer.己糖激酶 II 介导的糖酵解调控 ALK 阳性非小细胞肺癌对克唑替尼的敏感性。
Thorac Cancer. 2021 Dec;12(23):3184-3193. doi: 10.1111/1759-7714.14184. Epub 2021 Nov 2.
7
Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis.黄腐酚通过下调己糖激酶 II 介导的糖酵解抑制结直肠癌细胞。
Int J Biol Sci. 2019 Sep 7;15(11):2497-2508. doi: 10.7150/ijbs.37481. eCollection 2019.
8
Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.下调 miR-214 通过下调己糖激酶 2 和丙酮酸激酶同工酶 M2 的表达抑制非小细胞肺癌细胞的增殖和糖酵解。
Biomed Pharmacother. 2018 Sep;105:545-552. doi: 10.1016/j.biopha.2018.06.009. Epub 2018 Jun 7.
9
Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer Cells.表皮生长因子受体(EGFR)信号通路的抑制及线粒体凋亡的激活有助于丹参酮IIA介导的非小细胞肺癌细胞肿瘤抑制作用。
Onco Targets Ther. 2020 Apr 2;13:2757-2769. doi: 10.2147/OTT.S246606. eCollection 2020.
10
Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.丹参酮 IIA 通过降低 Akt-c-Myc 信号通路介导的有氧糖酵解抑制口腔鳞状细胞癌。
Cell Death Dis. 2020 May 18;11(5):381. doi: 10.1038/s41419-020-2579-9.

引用本文的文献

1
Therapeutic Strategies Targeting Aerobic Glycolysis in Cancer and Dynamic Monitoring of Associated Metabolites.针对癌症有氧糖酵解的治疗策略及相关代谢物的动态监测
Cells. 2025 Aug 19;14(16):1288. doi: 10.3390/cells14161288.
2
Metabolomic Insights into Sexual Multi-Morphism of Sinomenine Accumulation in .青藤碱积累性别的多态性的代谢组学见解
Plants (Basel). 2025 Jun 19;14(12):1885. doi: 10.3390/plants14121885.
3
Traditional Chinese Medicines as Anticancer Agents for Non-Small Cell Lung Cancer with EGFR Mutations: A Review.

本文引用的文献

1
Crucial players in glycolysis: Cancer progress.糖酵解中的关键角色:癌症进展。
Gene. 2020 Feb 5;726:144158. doi: 10.1016/j.gene.2019.144158. Epub 2019 Oct 17.
2
Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway.盐酸青藤碱通过负向调控 PI3K/AKT/Wnt 信号通路增强人胃癌细胞对顺铂的敏感性。
Anticancer Drugs. 2019 Nov;30(10):983-990. doi: 10.1097/CAD.0000000000000834.
3
Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.
用于治疗表皮生长因子受体(EGFR)突变的非小细胞肺癌的中药:综述
Drug Des Devel Ther. 2025 Jun 18;19:5169-5191. doi: 10.2147/DDDT.S522445. eCollection 2025.
4
Targeting the BMI1-Noxa axis by Dioscin induces apoptosis in oral squamous cell carcinoma cells.薯蓣皂苷通过靶向BMI1-Noxa轴诱导口腔鳞状细胞癌细胞凋亡。
J Cancer. 2025 Jan 1;16(1):110-121. doi: 10.7150/jca.100631. eCollection 2025.
5
Sinomenine ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the differentiation of fibroblast into myofibroblast.青藤碱通过抑制成纤维细胞向肌成纤维细胞分化来改善博来霉素诱导的肺纤维化。
Heliyon. 2024 Jun 24;10(13):e33314. doi: 10.1016/j.heliyon.2024.e33314. eCollection 2024 Jul 15.
6
Bioactivities and Mechanisms of Action of Sinomenine and Its Derivatives: A Comprehensive Review.青藤碱及其衍生物的生物活性与作用机制:综述
Molecules. 2024 Jan 22;29(2):540. doi: 10.3390/molecules29020540.
7
FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism.FFAR4 激活通过阻断与线粒体代谢相关的呼吸链复合物组装抑制肺腺癌。
Cell Mol Biol Lett. 2024 Jan 19;29(1):17. doi: 10.1186/s11658-024-00535-3.
8
The anti-tumor potential of sinomenine: a narrative review.青藤碱的抗肿瘤潜力:一篇叙述性综述。
Transl Cancer Res. 2023 Sep 30;12(9):2393-2404. doi: 10.21037/tcr-23-267. Epub 2023 Aug 15.
9
A new strategy for osteoarthritis therapy: Inhibition of glycolysis.骨关节炎治疗的新策略:抑制糖酵解。
Front Pharmacol. 2022 Nov 10;13:1057229. doi: 10.3389/fphar.2022.1057229. eCollection 2022.
10
Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy.靶向糖酵解信号通路的天然产物——抗癌治疗的最新综述
Front Pharmacol. 2022 Oct 20;13:1035882. doi: 10.3389/fphar.2022.1035882. eCollection 2022.
检查点抑制剂联合化疗用于晚期非小细胞肺癌一线治疗:一项随机对照试验的系统评价和荟萃分析
Future Sci OA. 2019 Sep 25;5(9):FSO421. doi: 10.2144/fsoa-2019-0081.
4
Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis.黄腐酚通过下调己糖激酶 II 介导的糖酵解抑制结直肠癌细胞。
Int J Biol Sci. 2019 Sep 7;15(11):2497-2508. doi: 10.7150/ijbs.37481. eCollection 2019.
5
Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung Cancer.肺癌免疫检查点抑制剂反应的预后因素和生物标志物。
Int J Mol Sci. 2019 Oct 5;20(19):4931. doi: 10.3390/ijms20194931.
6
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer.奥希替尼治疗 EGFR 突变型非小细胞肺癌的耐药机制。
Br J Cancer. 2019 Oct;121(9):725-737. doi: 10.1038/s41416-019-0573-8. Epub 2019 Sep 30.
7
Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis.青藤碱通过调节 miR-29/PDCD-4 轴抑制乳腺癌细胞增殖、迁移和侵袭。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3839-3846. doi: 10.1080/21691401.2019.1666861.
8
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.局部晚期和转移性非小细胞肺癌的系统治疗:综述。
JAMA. 2019 Aug 27;322(8):764-774. doi: 10.1001/jama.2019.11058.
9
Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.Skp2 介导的 Akt 泛素化和线粒体定位促进肿瘤生长和对顺铂的化疗耐药性。
Oncogene. 2019 Dec;38(50):7457-7472. doi: 10.1038/s41388-019-0955-7. Epub 2019 Aug 21.
10
Sinomenine exerts antitumour effect in gastric cancer cells via enhancement of miR-204 expression.青藤碱通过增强 miR-204 的表达发挥胃癌细胞的抗肿瘤作用。
Basic Clin Pharmacol Toxicol. 2019 Nov;125(5):450-459. doi: 10.1111/bcpt.13285. Epub 2019 Jul 17.